undefined undefined
NaN.000
NaN.00%
Immunic (NASDAQ:IMUX) reported quarterly losses of $(0.30) per share which missed the analyst consensus estimate of $(0.26) by 15.38 percent. This is a 48.28 percent increase over losses of $(0.58) per share from the
05-08 18:33
Analysts fell to the sidelines weighing in on Adaptimmune Therapeutics (ADAP – ...
04-16 14:50
Gainers: GCT Semiconductor Holding (GCTS) +88%. MediaCo Holding (MDIA) +79%. DigiAsia (FAAS) +49%. Hub Cyber Security (HUBC) +40% gets $8 million in financing; shares jump. Grindrod Shipping (GRIN)...
04-05 20:34
NEW YORK, March 7, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic infl...
03-07 19:30
The Dow Jones index closed lower by over 20 points on Wednesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.
02-29 23:40
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on revenue of $260.00 million.
02-22 18:27
Immunic (NASDAQ:IMUX) is set to give its latest quarterly earnings report on Th...
02-22 03:02
– Webcast to be Held at 8:00 am ET on February 22, 2024 – NEW YORK, Feb. 15, 2024 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of oral...
02-15 19:30
Aclarion, Inc. (NASDAQ: ACON) shares are trading higher Monday after the company announced it has executed a strategic partnership agreement solidifying the previously signed Letter of Intent (LOI) with Alphatec Spine, Inc.,
01-08 23:08
Immunic, Inc. (NASDAQ: IMUX) shares are roughly flat following strength early Friday after the company announced a three-tranche private placement of up to $240 million.
01-06 01:03